WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has asked Janet Woodcock, who has served as the FDA’s acting commissioner for the last 11 months, to stay on in a leadership role at the agency should he be confirmed by the Senate, two sources with knowledge of the discussion confirmed to STAT.
It’s still not clear exactly what Woodcock’s role would be or how she would split responsibilities with Califf, should she accept his offer. The most obvious role would be principal deputy commissioner, a position that amounts to second-in-charge at the agency and has been vacant since Amy Abernethy left it in April.
Create a display name to comment
This name will appear with your comment